Teva Pharmaceutical Industries Ltd. on Thursday announced it has entered into definitive agreements to acquire Rimsa, a leading pharmaceutical manufacturing and distribution company in Mexico. Read More »

GlaxoSmithKline Pharmaceuticals' (GSK) acquisition of Novartis Healthcare's vaccines business is complete, and GSK has sold its marketed oncology portfolio to Novartis India, while Novartis retains its influenza vaccine. Read More »

Teva Pharmaceutical Industries Ltd. and Gecko Health Innovations said late last week that they have entered into a definitive agreement in which Teva will acquire Gecko. Read More »

In a recent article on DrugChannels.net, Adam Fein, president of Pembroke Consulting and CEO of Pembroke's Drug Channels Institute, examined recent drug-spending forecasts from the Centers for Medicare and Medicaid Services (CMS), including the following predictions: Read More »

Janssen Biotech said on Monday that it has submitted a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration for front-line use in patients with chronic lymphocytic leukemia (CLL). Read More »

Generic-drug maker Mylan N.V. said on Monday that it has officially launched its formal offer to acquire all outstanding ordinary shares of Perrigo Co. Plc, based in Ireland. "With the overwhelming support of Mylan shareholders, today we officially are taking our offer directly to the Perrigo shareholders,” Mylan Executive Chairman Robert Coury said. Read More »

Adaptimmune Therapeutics, PLC announced Tuesday that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic that targets the NY-ESO-1 cancer antigen in synovial sarcoma patients. Read More »

Advaxis Inc. announced on Tuesday that its final clinical data from Stage 1 of the ongoing two-stage Phase 2 study of axalimogene filolisba in patients with persistent or recurrent metastatic carcinoma of the cervix will be presented at the American Gynecological & Obstetrical Society's annual meeting. Read More »

Lannett Company said this week that its Silarx Pharmaceuticals subsidiary received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Aripiprazole 1 mg/mL Oral Solution, the generic version of the antidepressant drug ABILIFY. Read More »

Price Chopper Supermarkets in New York has announced the acquisition of Fairway Pharmacy in Montrose, Pennsylvania, made effective on Monday. Read More »

Rite Aid Corporation today announced that seasonal flu shots are now available at all Rite Aid pharmacies nationwide. Read More »

Mylan N.V. on Wednesday announced the U.S. launch of Esomeprazole Magnesium Delayed-release Capsules USP, in 20 mg and 40 mg, which are the generic version of AstraZeneca's Nexium. Read More »

Teva Pharmaceutical Industries, Ltd. announced Monday it has signed a definitive agreement with Allergan, PLC to acquire Allergan Generics in a transaction valued at $40.5 billion.The strategic acquisition brings together two leading generics businesses with complementary strengths, brands and cultures. Read More »

Rite Aid has recently collaborated with HealthSpot to deploy telepresence pharmacy kiosks at 25 Rite Aid pharmacies across Ohio. Read More »

Aureus Health Services, a Specialty Pharmacy and Health Management Company, recently announced that it has gained Specialty Pharmacy Accreditation from the URAC. Read More »

Rite Aid, one of the leading drugstore chains in the U.S., and HealthSpot, an innovator in provider- and patient-driven health care technology, said on Monday that they have opened the first Telehealth stations in Ohio. Read More »

Mylan NV announced the launch of memantine hydrochloride tablets USP, 5 mg and 10 mg, the generic version of Forest's Namenda Tablets, in the United States on Tuesday. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, used for treating moderate to severe Alzheimer's-type dementia. Read More »

For the eighth consecutive year, Rite Aid is serving as the presenting sponsor of The Skin Cancer Foundation’s annual Road to Healthy Skin Tour, which started Monday. Read More »

Rite Aid Corp. yesterday announced that Bryan Everett will be the new executive vice president of store operations, effective Aug. 3. Read More »

Rite Aid has completed the acquisition of Envision Pharmaceutical Services from the global private investment firm TPG and other shareholders. Read More »